English
Mount Sinai Tisch Cancer Center
7.7K posts
Mount Sinai Tisch Cancer Center
@TischCancer
Leader in cancer prevention, detection, treatment & research. @IcahnMountSinai & @MountSinaiNYC Appointments: 1-844-MD CANCER
New York, NY Katılım Haziran 2014
955 Takip Edilen4.4K Takipçiler
Congratulations to @daniel_puleston and Sai Ma, PhD, recipients of the 2026 Dr. Harold and Golden Lamport Basic Science Research Award from the Icahn School of Medicine at Mount Sinai Faculty Council.
profiles.icahn.mssm.edu/daniel-puleston
profiles.icahn.mssm.edu/sai-ma
@IcahnMountSinai
English
Mount Sinai Tisch Cancer Center retweetledi
Quick basics on #Lymphoma #Immunotherapy how they work and how they fail in plain-speak:
bloodcancerstoday.com/videos/overcom…
and how our lab @MountSinaiNYC is working on fixes...
English
Ramon Parsons, MD, PhD, reflects on cancer care:
"...the most important thing a cancer hospital can be is fundamentally human: a space where excellent clinical outcomes and a compassionate patient experience are... inseparable."
give.mountsinai.org/our-commitment… #Hashtag
English
Mount Sinai Tisch Cancer Center retweetledi
Excited to share our new publication, “Biomarker Testing in NSCLC: Insights from Patients and Caregivers.” Proud to have served on the steering committee for this global survey of 357 patients and caregivers across 37 countries. @SinaiHemeOnc @TischCancer #NSCLC #LungCancer
PRECISION ONCOLOGY CONNECT powered by COR2ED@PresOnc_Connect
📣 Survey results published: Patient understanding of biomarker testing in non-small cell #lungcancer (NSCLC) We surveyed patients & caregivers to assess awareness, knowledge & attitudes surrounding #biomarkertesting in #NSCLC 📹 The results highlight gaps we can address to better support shared decision-making Download the Blueprint for full details/results PLUS a patient infographic to use in your clinic: cor2ed.com/precision-onco… From medical experts Prof. @ChristianRolfo, Prof. Fernando López-Ríos & Dr @Rparedes_MD, and made in collaboration with patient advocacy experts @acmoorephd, @BairdAM & Shani Shilo 🤝 This programme is endorsed by @LUNGevity, The Israeli Lung Cancer Foundation, @NTRKers & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer #MedEd #OncTwitter #ThoracicOncology #PrecisionMedicine
English
“Today’s FDA approvals represent a meaningful development for patients who have muscle-invasive bladder cancer...," said Matt Galsky, MD, @IcahnMountSinai #bladdercancer
Merck@Merck
Today, we announced the #FDA has approved two new treatments for certain patients with muscle-invasive #BladderCancer, expanding options for these patients. Learn more: go.merck.com/~app
English
Study from @sindhu_kunal and colleagues is the first nationwide analysis to systematically track individual radiation oncology practice sites.
mountsinai.org/about/newsroom…
@MountSinaiRO @IcahnMountSinai
Kunal Sindhu@sindhu_kunal
Happy to share our latest in @IJROBP Free-standing and rural practice sites have been more likely to disappear When rural counties lose a site, little capacity remains 68.5% of US counties, home to 50.8M Americans, lack RO access @JaredRowleyMD redjournal.org/article/S0360-…
English
Congratulations to Igor Bado, PhD, and Elvin Wagenblast, PhD, recipients of the 2026 Junior Faculty Award from the Icahn School of Medicine at Mount Sinai Faculty Council.
@BadoIgor @Elvin_Wag @IcahnMountSinai
English
Mount Sinai Tisch Cancer Center retweetledi
Training the next generation of physicians means teaching them to see the full picture. Dr. Kenneth L. Davis reflects that the factors that most influence how a patient fares–economic, social, and environmental–are not yet central enough to medical training. Integrating these variables into the curriculum is what will equip future physicians to identify what is driving poor outcomes and intervene in ways that actually make a difference.
#AspenIdeas #AspenIdeasHealth #MedicalEducation
English
A ceremonial groundbreaking for the Mount Sinai Tisch Cancer Hospital took place June 1. With support from philanthropic leaders James S. Tisch and Merryl H. Tisch, EdD, the hospital will blend breakthrough science and whole-person care. give.mountsinai.org/stories/mount-…
@MountSinaiNYC
English
Resistance to Immune Checkpoint Inhibitor Treatment in Non–Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…
@DDoroshow @fred_hirsch @IcahnMountSinai #lungcancer
English
Wearable devices detect CRS earlier after CAR T-cell therapy healio.com/news/hematolog…
Samir Parekh, MD, explains. @IcahnMountSinai
English
Noa Rippel, MD, and colleagues have identified a previously underrecognized folate deficiency that may cause severe anemia in some patients receiving PARP inhibitors.
mountsinai.org/about/newsroom…
@NRippelMD @IcahnMountSinai
English
Mount Sinai Tisch Cancer Center retweetledi
Ask Google Gemini "what hospital has done the most to advance in situ vaccination" and see why I'm grateful to be @MountSinaiNYC @SinaiImmunol @TischCancer!
Thanks @Blood_Cancers for chatting on in situ vaccination, progress, melting tumors away! bit.ly/4ePtyM7
English
Mount Sinai Tisch Cancer Center retweetledi
As one of the inaugural graduates of the first integrated oncology and palliative medicine fellowship, I spend a lot of time wondering how we can make palliative care more accessible to every patient with cancer. Primary palliative care has to be part of the solution. @PallOncCoP
English
Congratulations to Andrew Ji, MD, recipient of the 2026 Dr. Harold and Golden Lamport Clinical Research Award from the Icahn School of Medicine at Mount Sinai Faculty Council.
@andrewlji @IcahnMountSinai
.
English
John Mascarenhas, MD, @IcahnMountSinai, discusses phase 3 SENTRY trial - a trial of 60 mg selinexor in combination with ruxolitinib vs placebo + ruxolitinib in pts with JAK inhibitor–naïve myelofibrosis.
youtu.be/zcuCyHckKrM?si… via @YouTube
YouTube
Română
.@JoshuaRichterMD tells patients "myeloma may be curable — and we may be able to cure you."
onclive.com/view/from-not-…
@IcahnMountSinai #MultipleMyeloma
English
Congratulations to Janice Gabrilove, MD, recipient of the 2026 Lifetime Achievement Award from the Faculty Council of the Icahn School of Medicine at Mount Sinai, @IcahnMountSinai.
profiles.mountsinai.org/janice-l-gabri…
English